nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ADRB1—stomach cancer	0.37	0.543	CbGaD
Metoprolol—ADRB2—stomach cancer	0.311	0.457	CbGaD
Metoprolol—ABCB1—Mitomycin—stomach cancer	0.0788	0.54	CbGbCtD
Metoprolol—ABCB1—Irinotecan—stomach cancer	0.0202	0.138	CbGbCtD
Metoprolol—ABCB1—Docetaxel—stomach cancer	0.0148	0.101	CbGbCtD
Metoprolol—ABCB1—Doxorubicin—stomach cancer	0.011	0.0757	CbGbCtD
Metoprolol—ABCB1—Methotrexate—stomach cancer	0.0107	0.0733	CbGbCtD
Metoprolol—CYP2D6—Doxorubicin—stomach cancer	0.0104	0.0713	CbGbCtD
Metoprolol—Practolol—ADRB1—stomach cancer	0.00053	0.0626	CrCbGaD
Metoprolol—Metipranolol—ADRB1—stomach cancer	0.000479	0.0566	CrCbGaD
Metoprolol—Sotalol—ADRB1—stomach cancer	0.000427	0.0505	CrCbGaD
Metoprolol—Metipranolol—ADRB2—stomach cancer	0.000403	0.0476	CrCbGaD
Metoprolol—Esmolol—ADRB1—stomach cancer	0.000381	0.045	CrCbGaD
Metoprolol—Bevantolol—ADRB1—stomach cancer	0.000376	0.0444	CrCbGaD
Metoprolol—Sotalol—ADRB2—stomach cancer	0.000359	0.0424	CrCbGaD
Metoprolol—Betaxolol—ADRB1—stomach cancer	0.000335	0.0396	CrCbGaD
Metoprolol—Atenolol—ADRB1—stomach cancer	0.000332	0.0392	CrCbGaD
Metoprolol—Bisoprolol—ADRB1—stomach cancer	0.000324	0.0382	CrCbGaD
Metoprolol—Esmolol—ADRB2—stomach cancer	0.00032	0.0378	CrCbGaD
Metoprolol—Bevantolol—ADRB2—stomach cancer	0.000316	0.0374	CrCbGaD
Metoprolol—Acebutolol—ADRB1—stomach cancer	0.000307	0.0362	CrCbGaD
Metoprolol—Oxprenolol—ADRB1—stomach cancer	0.000305	0.036	CrCbGaD
Metoprolol—Betaxolol—ADRB2—stomach cancer	0.000282	0.0333	CrCbGaD
Metoprolol—Atenolol—ADRB2—stomach cancer	0.000279	0.033	CrCbGaD
Metoprolol—Alprenolol—ADRB1—stomach cancer	0.000279	0.0329	CrCbGaD
Metoprolol—Bisoprolol—ADRB2—stomach cancer	0.000272	0.0322	CrCbGaD
Metoprolol—Acebutolol—ADRB2—stomach cancer	0.000258	0.0305	CrCbGaD
Metoprolol—Oxprenolol—ADRB2—stomach cancer	0.000256	0.0302	CrCbGaD
Metoprolol—Alprenolol—HTR1A—stomach cancer	0.000249	0.0294	CrCbGaD
Metoprolol—Pindolol—ADRB1—stomach cancer	0.00024	0.0283	CrCbGaD
Metoprolol—Alprenolol—ADRB2—stomach cancer	0.000234	0.0277	CrCbGaD
Metoprolol—Pindolol—HTR1A—stomach cancer	0.000214	0.0253	CrCbGaD
Metoprolol—Pindolol—ADRB2—stomach cancer	0.000201	0.0238	CrCbGaD
Metoprolol—Chlorphenesin—PTGS2—stomach cancer	0.00015	0.0177	CrCbGaD
Metoprolol—Dizziness—Irinotecan—stomach cancer	0.000141	0.000938	CcSEcCtD
Metoprolol—Jaundice—Doxorubicin—stomach cancer	0.00014	0.000935	CcSEcCtD
Metoprolol—Shock—Capecitabine—stomach cancer	0.00014	0.000934	CcSEcCtD
Metoprolol—Rhinitis—Epirubicin—stomach cancer	0.00014	0.000933	CcSEcCtD
Metoprolol—Conjunctivitis—Doxorubicin—stomach cancer	0.00014	0.000932	CcSEcCtD
Metoprolol—Nervous system disorder—Capecitabine—stomach cancer	0.00014	0.000931	CcSEcCtD
Metoprolol—Hepatitis—Epirubicin—stomach cancer	0.00014	0.00093	CcSEcCtD
Metoprolol—Eye disorder—Methotrexate—stomach cancer	0.000139	0.000929	CcSEcCtD
Metoprolol—Diarrhoea—Fluorouracil—stomach cancer	0.000139	0.000929	CcSEcCtD
Metoprolol—Thrombocytopenia—Capecitabine—stomach cancer	0.000139	0.000929	CcSEcCtD
Metoprolol—Tinnitus—Methotrexate—stomach cancer	0.000139	0.000927	CcSEcCtD
Metoprolol—Tachycardia—Capecitabine—stomach cancer	0.000139	0.000926	CcSEcCtD
Metoprolol—Cardiac disorder—Methotrexate—stomach cancer	0.000138	0.000923	CcSEcCtD
Metoprolol—Skin disorder—Capecitabine—stomach cancer	0.000138	0.000922	CcSEcCtD
Metoprolol—Sweating—Doxorubicin—stomach cancer	0.000138	0.000919	CcSEcCtD
Metoprolol—Hyperhidrosis—Capecitabine—stomach cancer	0.000138	0.000917	CcSEcCtD
Metoprolol—Oedema peripheral—Epirubicin—stomach cancer	0.000138	0.000917	CcSEcCtD
Metoprolol—Hypotension—Docetaxel—stomach cancer	0.000137	0.000916	CcSEcCtD
Metoprolol—Connective tissue disorder—Epirubicin—stomach cancer	0.000137	0.000914	CcSEcCtD
Metoprolol—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000136	0.000907	CcSEcCtD
Metoprolol—Angiopathy—Methotrexate—stomach cancer	0.000135	0.000902	CcSEcCtD
Metoprolol—Vomiting—Irinotecan—stomach cancer	0.000135	0.000901	CcSEcCtD
Metoprolol—Immune system disorder—Methotrexate—stomach cancer	0.000135	0.000898	CcSEcCtD
Metoprolol—Dizziness—Fluorouracil—stomach cancer	0.000135	0.000898	CcSEcCtD
Metoprolol—Visual impairment—Epirubicin—stomach cancer	0.000135	0.000897	CcSEcCtD
Metoprolol—Mediastinal disorder—Methotrexate—stomach cancer	0.000134	0.000896	CcSEcCtD
Metoprolol—Agranulocytosis—Doxorubicin—stomach cancer	0.000134	0.000895	CcSEcCtD
Metoprolol—Rash—Irinotecan—stomach cancer	0.000134	0.000894	CcSEcCtD
Metoprolol—Dermatitis—Irinotecan—stomach cancer	0.000134	0.000893	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000134	0.000893	CcSEcCtD
Metoprolol—Headache—Irinotecan—stomach cancer	0.000133	0.000888	CcSEcCtD
Metoprolol—Hypotension—Capecitabine—stomach cancer	0.000133	0.000887	CcSEcCtD
Metoprolol—Insomnia—Docetaxel—stomach cancer	0.000133	0.000886	CcSEcCtD
Metoprolol—Paraesthesia—Docetaxel—stomach cancer	0.000132	0.00088	CcSEcCtD
Metoprolol—Alopecia—Methotrexate—stomach cancer	0.000132	0.000879	CcSEcCtD
Metoprolol—Bradycardia—Doxorubicin—stomach cancer	0.000132	0.000876	CcSEcCtD
Metoprolol—Dyspnoea—Docetaxel—stomach cancer	0.000131	0.000874	CcSEcCtD
Metoprolol—Somnolence—Docetaxel—stomach cancer	0.000131	0.000871	CcSEcCtD
Metoprolol—Mental disorder—Methotrexate—stomach cancer	0.000131	0.000871	CcSEcCtD
Metoprolol—Propranolol—ADRB1—stomach cancer	0.000131	0.0154	CrCbGaD
Metoprolol—Eye disorder—Epirubicin—stomach cancer	0.000131	0.00087	CcSEcCtD
Metoprolol—Tinnitus—Epirubicin—stomach cancer	0.00013	0.000868	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00013	0.000865	CcSEcCtD
Metoprolol—Cardiac disorder—Epirubicin—stomach cancer	0.00013	0.000864	CcSEcCtD
Metoprolol—Vomiting—Fluorouracil—stomach cancer	0.00013	0.000863	CcSEcCtD
Metoprolol—Rhinitis—Doxorubicin—stomach cancer	0.00013	0.000863	CcSEcCtD
Metoprolol—Dyspepsia—Docetaxel—stomach cancer	0.000129	0.000863	CcSEcCtD
Metoprolol—Hepatitis—Doxorubicin—stomach cancer	0.000129	0.000861	CcSEcCtD
Metoprolol—Insomnia—Capecitabine—stomach cancer	0.000129	0.000858	CcSEcCtD
Metoprolol—Rash—Fluorouracil—stomach cancer	0.000129	0.000856	CcSEcCtD
Metoprolol—Dermatitis—Fluorouracil—stomach cancer	0.000128	0.000855	CcSEcCtD
Metoprolol—Paraesthesia—Capecitabine—stomach cancer	0.000128	0.000852	CcSEcCtD
Metoprolol—Headache—Fluorouracil—stomach cancer	0.000128	0.000851	CcSEcCtD
Metoprolol—Oedema peripheral—Doxorubicin—stomach cancer	0.000127	0.000848	CcSEcCtD
Metoprolol—Dysgeusia—Methotrexate—stomach cancer	0.000127	0.000848	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000127	0.000846	CcSEcCtD
Metoprolol—Connective tissue disorder—Doxorubicin—stomach cancer	0.000127	0.000846	CcSEcCtD
Metoprolol—Dyspnoea—Capecitabine—stomach cancer	0.000127	0.000846	CcSEcCtD
Metoprolol—Fatigue—Docetaxel—stomach cancer	0.000127	0.000845	CcSEcCtD
Metoprolol—Angiopathy—Epirubicin—stomach cancer	0.000127	0.000844	CcSEcCtD
Metoprolol—Nausea—Irinotecan—stomach cancer	0.000126	0.000842	CcSEcCtD
Metoprolol—Immune system disorder—Epirubicin—stomach cancer	0.000126	0.00084	CcSEcCtD
Metoprolol—Mediastinal disorder—Epirubicin—stomach cancer	0.000126	0.000839	CcSEcCtD
Metoprolol—Pain—Docetaxel—stomach cancer	0.000126	0.000838	CcSEcCtD
Metoprolol—Constipation—Docetaxel—stomach cancer	0.000126	0.000838	CcSEcCtD
Metoprolol—Dyspepsia—Capecitabine—stomach cancer	0.000125	0.000835	CcSEcCtD
Metoprolol—Arrhythmia—Epirubicin—stomach cancer	0.000125	0.000831	CcSEcCtD
Metoprolol—Visual impairment—Doxorubicin—stomach cancer	0.000125	0.00083	CcSEcCtD
Metoprolol—Alopecia—Epirubicin—stomach cancer	0.000123	0.000822	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000123	0.000819	CcSEcCtD
Metoprolol—Fatigue—Capecitabine—stomach cancer	0.000123	0.000818	CcSEcCtD
Metoprolol—Vision blurred—Methotrexate—stomach cancer	0.000122	0.000816	CcSEcCtD
Metoprolol—Mental disorder—Epirubicin—stomach cancer	0.000122	0.000815	CcSEcCtD
Metoprolol—Constipation—Capecitabine—stomach cancer	0.000122	0.000811	CcSEcCtD
Metoprolol—Pain—Capecitabine—stomach cancer	0.000122	0.000811	CcSEcCtD
Metoprolol—Feeling abnormal—Docetaxel—stomach cancer	0.000121	0.000808	CcSEcCtD
Metoprolol—Nausea—Fluorouracil—stomach cancer	0.000121	0.000807	CcSEcCtD
Metoprolol—Eye disorder—Doxorubicin—stomach cancer	0.000121	0.000805	CcSEcCtD
Metoprolol—Tinnitus—Doxorubicin—stomach cancer	0.00012	0.000803	CcSEcCtD
Metoprolol—Gastrointestinal pain—Docetaxel—stomach cancer	0.00012	0.000801	CcSEcCtD
Metoprolol—Cardiac disorder—Doxorubicin—stomach cancer	0.00012	0.000799	CcSEcCtD
Metoprolol—Flatulence—Epirubicin—stomach cancer	0.00012	0.000798	CcSEcCtD
Metoprolol—Tension—Epirubicin—stomach cancer	0.000119	0.000795	CcSEcCtD
Metoprolol—Dysgeusia—Epirubicin—stomach cancer	0.000119	0.000793	CcSEcCtD
Metoprolol—Nervousness—Epirubicin—stomach cancer	0.000118	0.000787	CcSEcCtD
Metoprolol—Feeling abnormal—Capecitabine—stomach cancer	0.000117	0.000782	CcSEcCtD
Metoprolol—Angiopathy—Doxorubicin—stomach cancer	0.000117	0.000781	CcSEcCtD
Metoprolol—Propranolol—HTR1A—stomach cancer	0.000117	0.0138	CrCbGaD
Metoprolol—Muscle spasms—Epirubicin—stomach cancer	0.000117	0.000779	CcSEcCtD
Metoprolol—Immune system disorder—Doxorubicin—stomach cancer	0.000117	0.000778	CcSEcCtD
Metoprolol—Vertigo—Methotrexate—stomach cancer	0.000117	0.000778	CcSEcCtD
Metoprolol—Gastrointestinal pain—Capecitabine—stomach cancer	0.000116	0.000776	CcSEcCtD
Metoprolol—Mediastinal disorder—Doxorubicin—stomach cancer	0.000116	0.000776	CcSEcCtD
Metoprolol—Abdominal pain—Docetaxel—stomach cancer	0.000116	0.000775	CcSEcCtD
Metoprolol—Body temperature increased—Docetaxel—stomach cancer	0.000116	0.000775	CcSEcCtD
Metoprolol—Leukopenia—Methotrexate—stomach cancer	0.000116	0.000775	CcSEcCtD
Metoprolol—Arrhythmia—Doxorubicin—stomach cancer	0.000115	0.000769	CcSEcCtD
Metoprolol—Vision blurred—Epirubicin—stomach cancer	0.000115	0.000763	CcSEcCtD
Metoprolol—Alopecia—Doxorubicin—stomach cancer	0.000114	0.000761	CcSEcCtD
Metoprolol—Mental disorder—Doxorubicin—stomach cancer	0.000113	0.000754	CcSEcCtD
Metoprolol—Urticaria—Capecitabine—stomach cancer	0.000113	0.000754	CcSEcCtD
Metoprolol—Abdominal pain—Capecitabine—stomach cancer	0.000113	0.00075	CcSEcCtD
Metoprolol—Body temperature increased—Capecitabine—stomach cancer	0.000113	0.00075	CcSEcCtD
Metoprolol—Flatulence—Doxorubicin—stomach cancer	0.000111	0.000739	CcSEcCtD
Metoprolol—Arthralgia—Methotrexate—stomach cancer	0.000111	0.000737	CcSEcCtD
Metoprolol—Chest pain—Methotrexate—stomach cancer	0.000111	0.000737	CcSEcCtD
Metoprolol—Tension—Doxorubicin—stomach cancer	0.00011	0.000735	CcSEcCtD
Metoprolol—Dysgeusia—Doxorubicin—stomach cancer	0.00011	0.000734	CcSEcCtD
Metoprolol—Propranolol—ADRB2—stomach cancer	0.00011	0.013	CrCbGaD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00011	0.000732	CcSEcCtD
Metoprolol—Nervousness—Doxorubicin—stomach cancer	0.000109	0.000728	CcSEcCtD
Metoprolol—Vertigo—Epirubicin—stomach cancer	0.000109	0.000728	CcSEcCtD
Metoprolol—Syncope—Epirubicin—stomach cancer	0.000109	0.000726	CcSEcCtD
Metoprolol—Leukopenia—Epirubicin—stomach cancer	0.000109	0.000725	CcSEcCtD
Metoprolol—Hypersensitivity—Docetaxel—stomach cancer	0.000108	0.000722	CcSEcCtD
Metoprolol—Muscle spasms—Doxorubicin—stomach cancer	0.000108	0.000721	CcSEcCtD
Metoprolol—Palpitations—Epirubicin—stomach cancer	0.000107	0.000716	CcSEcCtD
Metoprolol—Confusional state—Methotrexate—stomach cancer	0.000107	0.000712	CcSEcCtD
Metoprolol—Loss of consciousness—Epirubicin—stomach cancer	0.000107	0.000712	CcSEcCtD
Metoprolol—Vision blurred—Doxorubicin—stomach cancer	0.000106	0.000706	CcSEcCtD
Metoprolol—Asthenia—Docetaxel—stomach cancer	0.000106	0.000703	CcSEcCtD
Metoprolol—Hypertension—Epirubicin—stomach cancer	0.000105	0.000699	CcSEcCtD
Metoprolol—Hypersensitivity—Capecitabine—stomach cancer	0.000105	0.000699	CcSEcCtD
Metoprolol—Pruritus—Docetaxel—stomach cancer	0.000104	0.000693	CcSEcCtD
Metoprolol—Nervous system disorder—Methotrexate—stomach cancer	0.000104	0.000693	CcSEcCtD
Metoprolol—Thrombocytopenia—Methotrexate—stomach cancer	0.000104	0.000692	CcSEcCtD
Metoprolol—Chest pain—Epirubicin—stomach cancer	0.000104	0.00069	CcSEcCtD
Metoprolol—Arthralgia—Epirubicin—stomach cancer	0.000104	0.00069	CcSEcCtD
Metoprolol—Anxiety—Epirubicin—stomach cancer	0.000103	0.000687	CcSEcCtD
Metoprolol—Skin disorder—Methotrexate—stomach cancer	0.000103	0.000686	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000103	0.000685	CcSEcCtD
Metoprolol—Hyperhidrosis—Methotrexate—stomach cancer	0.000102	0.000683	CcSEcCtD
Metoprolol—Asthenia—Capecitabine—stomach cancer	0.000102	0.000681	CcSEcCtD
Metoprolol—Dry mouth—Epirubicin—stomach cancer	0.000101	0.000674	CcSEcCtD
Metoprolol—Vertigo—Doxorubicin—stomach cancer	0.000101	0.000673	CcSEcCtD
Metoprolol—Syncope—Doxorubicin—stomach cancer	0.000101	0.000672	CcSEcCtD
Metoprolol—Pruritus—Capecitabine—stomach cancer	0.000101	0.000671	CcSEcCtD
Metoprolol—Leukopenia—Doxorubicin—stomach cancer	0.000101	0.000671	CcSEcCtD
Metoprolol—Diarrhoea—Docetaxel—stomach cancer	0.000101	0.000671	CcSEcCtD
Metoprolol—Confusional state—Epirubicin—stomach cancer	0.0001	0.000667	CcSEcCtD
Metoprolol—Palpitations—Doxorubicin—stomach cancer	9.94e-05	0.000662	CcSEcCtD
Metoprolol—Oedema—Epirubicin—stomach cancer	9.92e-05	0.000661	CcSEcCtD
Metoprolol—Hypotension—Methotrexate—stomach cancer	9.91e-05	0.00066	CcSEcCtD
Metoprolol—Loss of consciousness—Doxorubicin—stomach cancer	9.89e-05	0.000659	CcSEcCtD
Metoprolol—Shock—Epirubicin—stomach cancer	9.76e-05	0.00065	CcSEcCtD
Metoprolol—Diarrhoea—Capecitabine—stomach cancer	9.74e-05	0.000649	CcSEcCtD
Metoprolol—Nervous system disorder—Epirubicin—stomach cancer	9.73e-05	0.000648	CcSEcCtD
Metoprolol—Dizziness—Docetaxel—stomach cancer	9.73e-05	0.000648	CcSEcCtD
Metoprolol—Thrombocytopenia—Epirubicin—stomach cancer	9.71e-05	0.000647	CcSEcCtD
Metoprolol—Hypertension—Doxorubicin—stomach cancer	9.71e-05	0.000647	CcSEcCtD
Metoprolol—Tachycardia—Epirubicin—stomach cancer	9.68e-05	0.000645	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Methotrexate—stomach cancer	9.66e-05	0.000644	CcSEcCtD
Metoprolol—Skin disorder—Epirubicin—stomach cancer	9.64e-05	0.000642	CcSEcCtD
Metoprolol—Hyperhidrosis—Epirubicin—stomach cancer	9.59e-05	0.000639	CcSEcCtD
Metoprolol—Insomnia—Methotrexate—stomach cancer	9.59e-05	0.000639	CcSEcCtD
Metoprolol—Arthralgia—Doxorubicin—stomach cancer	9.58e-05	0.000638	CcSEcCtD
Metoprolol—Chest pain—Doxorubicin—stomach cancer	9.58e-05	0.000638	CcSEcCtD
Metoprolol—Anxiety—Doxorubicin—stomach cancer	9.54e-05	0.000636	CcSEcCtD
Metoprolol—Paraesthesia—Methotrexate—stomach cancer	9.52e-05	0.000634	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	9.51e-05	0.000634	CcSEcCtD
Metoprolol—Dyspnoea—Methotrexate—stomach cancer	9.45e-05	0.00063	CcSEcCtD
Metoprolol—Somnolence—Methotrexate—stomach cancer	9.43e-05	0.000628	CcSEcCtD
Metoprolol—Dizziness—Capecitabine—stomach cancer	9.42e-05	0.000628	CcSEcCtD
Metoprolol—Dry mouth—Doxorubicin—stomach cancer	9.37e-05	0.000624	CcSEcCtD
Metoprolol—Vomiting—Docetaxel—stomach cancer	9.35e-05	0.000623	CcSEcCtD
Metoprolol—Dyspepsia—Methotrexate—stomach cancer	9.33e-05	0.000622	CcSEcCtD
Metoprolol—Rash—Docetaxel—stomach cancer	9.28e-05	0.000618	CcSEcCtD
Metoprolol—Hypotension—Epirubicin—stomach cancer	9.27e-05	0.000618	CcSEcCtD
Metoprolol—Dermatitis—Docetaxel—stomach cancer	9.27e-05	0.000617	CcSEcCtD
Metoprolol—Confusional state—Doxorubicin—stomach cancer	9.26e-05	0.000617	CcSEcCtD
Metoprolol—Headache—Docetaxel—stomach cancer	9.22e-05	0.000614	CcSEcCtD
Metoprolol—Oedema—Doxorubicin—stomach cancer	9.18e-05	0.000612	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Methotrexate—stomach cancer	9.15e-05	0.00061	CcSEcCtD
Metoprolol—Fatigue—Methotrexate—stomach cancer	9.14e-05	0.000609	CcSEcCtD
Metoprolol—Pain—Methotrexate—stomach cancer	9.07e-05	0.000604	CcSEcCtD
Metoprolol—Vomiting—Capecitabine—stomach cancer	9.06e-05	0.000603	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Epirubicin—stomach cancer	9.04e-05	0.000602	CcSEcCtD
Metoprolol—Shock—Doxorubicin—stomach cancer	9.03e-05	0.000602	CcSEcCtD
Metoprolol—Nervous system disorder—Doxorubicin—stomach cancer	9e-05	0.0006	CcSEcCtD
Metoprolol—Thrombocytopenia—Doxorubicin—stomach cancer	8.99e-05	0.000599	CcSEcCtD
Metoprolol—Rash—Capecitabine—stomach cancer	8.98e-05	0.000598	CcSEcCtD
Metoprolol—Insomnia—Epirubicin—stomach cancer	8.97e-05	0.000598	CcSEcCtD
Metoprolol—Dermatitis—Capecitabine—stomach cancer	8.97e-05	0.000598	CcSEcCtD
Metoprolol—Tachycardia—Doxorubicin—stomach cancer	8.96e-05	0.000597	CcSEcCtD
Metoprolol—Headache—Capecitabine—stomach cancer	8.92e-05	0.000594	CcSEcCtD
Metoprolol—Skin disorder—Doxorubicin—stomach cancer	8.92e-05	0.000594	CcSEcCtD
Metoprolol—Paraesthesia—Epirubicin—stomach cancer	8.91e-05	0.000594	CcSEcCtD
Metoprolol—Hyperhidrosis—Doxorubicin—stomach cancer	8.88e-05	0.000591	CcSEcCtD
Metoprolol—Dyspnoea—Epirubicin—stomach cancer	8.85e-05	0.000589	CcSEcCtD
Metoprolol—Somnolence—Epirubicin—stomach cancer	8.82e-05	0.000588	CcSEcCtD
Metoprolol—Nausea—Docetaxel—stomach cancer	8.74e-05	0.000582	CcSEcCtD
Metoprolol—Feeling abnormal—Methotrexate—stomach cancer	8.74e-05	0.000582	CcSEcCtD
Metoprolol—Dyspepsia—Epirubicin—stomach cancer	8.73e-05	0.000582	CcSEcCtD
Metoprolol—Gastrointestinal pain—Methotrexate—stomach cancer	8.67e-05	0.000578	CcSEcCtD
Metoprolol—Hypotension—Doxorubicin—stomach cancer	8.58e-05	0.000572	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Epirubicin—stomach cancer	8.57e-05	0.000571	CcSEcCtD
Metoprolol—Fatigue—Epirubicin—stomach cancer	8.55e-05	0.00057	CcSEcCtD
Metoprolol—Pain—Epirubicin—stomach cancer	8.48e-05	0.000565	CcSEcCtD
Metoprolol—Constipation—Epirubicin—stomach cancer	8.48e-05	0.000565	CcSEcCtD
Metoprolol—Nausea—Capecitabine—stomach cancer	8.46e-05	0.000564	CcSEcCtD
Metoprolol—Urticaria—Methotrexate—stomach cancer	8.42e-05	0.000561	CcSEcCtD
Metoprolol—Body temperature increased—Methotrexate—stomach cancer	8.38e-05	0.000558	CcSEcCtD
Metoprolol—Abdominal pain—Methotrexate—stomach cancer	8.38e-05	0.000558	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	8.36e-05	0.000557	CcSEcCtD
Metoprolol—Insomnia—Doxorubicin—stomach cancer	8.3e-05	0.000553	CcSEcCtD
Metoprolol—Paraesthesia—Doxorubicin—stomach cancer	8.24e-05	0.000549	CcSEcCtD
Metoprolol—Dyspnoea—Doxorubicin—stomach cancer	8.18e-05	0.000545	CcSEcCtD
Metoprolol—Feeling abnormal—Epirubicin—stomach cancer	8.18e-05	0.000545	CcSEcCtD
Metoprolol—Somnolence—Doxorubicin—stomach cancer	8.16e-05	0.000544	CcSEcCtD
Metoprolol—Gastrointestinal pain—Epirubicin—stomach cancer	8.11e-05	0.000541	CcSEcCtD
Metoprolol—Dyspepsia—Doxorubicin—stomach cancer	8.08e-05	0.000538	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Doxorubicin—stomach cancer	7.93e-05	0.000528	CcSEcCtD
Metoprolol—Fatigue—Doxorubicin—stomach cancer	7.92e-05	0.000527	CcSEcCtD
Metoprolol—Urticaria—Epirubicin—stomach cancer	7.88e-05	0.000525	CcSEcCtD
Metoprolol—Pain—Doxorubicin—stomach cancer	7.85e-05	0.000523	CcSEcCtD
Metoprolol—Constipation—Doxorubicin—stomach cancer	7.85e-05	0.000523	CcSEcCtD
Metoprolol—Abdominal pain—Epirubicin—stomach cancer	7.84e-05	0.000523	CcSEcCtD
Metoprolol—Body temperature increased—Epirubicin—stomach cancer	7.84e-05	0.000523	CcSEcCtD
Metoprolol—Hypersensitivity—Methotrexate—stomach cancer	7.81e-05	0.00052	CcSEcCtD
Metoprolol—Asthenia—Methotrexate—stomach cancer	7.61e-05	0.000507	CcSEcCtD
Metoprolol—Feeling abnormal—Doxorubicin—stomach cancer	7.57e-05	0.000504	CcSEcCtD
Metoprolol—Gastrointestinal pain—Doxorubicin—stomach cancer	7.51e-05	0.0005	CcSEcCtD
Metoprolol—Pruritus—Methotrexate—stomach cancer	7.5e-05	0.0005	CcSEcCtD
Metoprolol—Hypersensitivity—Epirubicin—stomach cancer	7.31e-05	0.000487	CcSEcCtD
Metoprolol—Urticaria—Doxorubicin—stomach cancer	7.29e-05	0.000486	CcSEcCtD
Metoprolol—Abdominal pain—Doxorubicin—stomach cancer	7.26e-05	0.000484	CcSEcCtD
Metoprolol—Body temperature increased—Doxorubicin—stomach cancer	7.26e-05	0.000484	CcSEcCtD
Metoprolol—Diarrhoea—Methotrexate—stomach cancer	7.25e-05	0.000483	CcSEcCtD
Metoprolol—Asthenia—Epirubicin—stomach cancer	7.12e-05	0.000474	CcSEcCtD
Metoprolol—Pruritus—Epirubicin—stomach cancer	7.02e-05	0.000468	CcSEcCtD
Metoprolol—Dizziness—Methotrexate—stomach cancer	7.01e-05	0.000467	CcSEcCtD
Metoprolol—Diarrhoea—Epirubicin—stomach cancer	6.79e-05	0.000452	CcSEcCtD
Metoprolol—Hypersensitivity—Doxorubicin—stomach cancer	6.76e-05	0.000451	CcSEcCtD
Metoprolol—Vomiting—Methotrexate—stomach cancer	6.74e-05	0.000449	CcSEcCtD
Metoprolol—Rash—Methotrexate—stomach cancer	6.68e-05	0.000445	CcSEcCtD
Metoprolol—Dermatitis—Methotrexate—stomach cancer	6.68e-05	0.000445	CcSEcCtD
Metoprolol—Headache—Methotrexate—stomach cancer	6.64e-05	0.000443	CcSEcCtD
Metoprolol—Asthenia—Doxorubicin—stomach cancer	6.59e-05	0.000439	CcSEcCtD
Metoprolol—Dizziness—Epirubicin—stomach cancer	6.56e-05	0.000437	CcSEcCtD
Metoprolol—Pruritus—Doxorubicin—stomach cancer	6.5e-05	0.000433	CcSEcCtD
Metoprolol—Vomiting—Epirubicin—stomach cancer	6.31e-05	0.00042	CcSEcCtD
Metoprolol—Nausea—Methotrexate—stomach cancer	6.3e-05	0.00042	CcSEcCtD
Metoprolol—Diarrhoea—Doxorubicin—stomach cancer	6.28e-05	0.000419	CcSEcCtD
Metoprolol—Rash—Epirubicin—stomach cancer	6.26e-05	0.000417	CcSEcCtD
Metoprolol—Dermatitis—Epirubicin—stomach cancer	6.25e-05	0.000416	CcSEcCtD
Metoprolol—Headache—Epirubicin—stomach cancer	6.22e-05	0.000414	CcSEcCtD
Metoprolol—Dizziness—Doxorubicin—stomach cancer	6.07e-05	0.000404	CcSEcCtD
Metoprolol—Nausea—Epirubicin—stomach cancer	5.89e-05	0.000393	CcSEcCtD
Metoprolol—Vomiting—Doxorubicin—stomach cancer	5.84e-05	0.000389	CcSEcCtD
Metoprolol—Rash—Doxorubicin—stomach cancer	5.79e-05	0.000386	CcSEcCtD
Metoprolol—Dermatitis—Doxorubicin—stomach cancer	5.78e-05	0.000385	CcSEcCtD
Metoprolol—Headache—Doxorubicin—stomach cancer	5.75e-05	0.000383	CcSEcCtD
Metoprolol—Nausea—Doxorubicin—stomach cancer	5.45e-05	0.000363	CcSEcCtD
Metoprolol—CYP2D6—Metabolism—CA2—stomach cancer	8.7e-06	0.000572	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ENO1—stomach cancer	8.65e-06	0.000569	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PLCE1—stomach cancer	8.58e-06	0.000565	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALDH7A1—stomach cancer	8.58e-06	0.000565	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	8.51e-06	0.00056	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NT5E—stomach cancer	8.48e-06	0.000558	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PGAM1—stomach cancer	8.48e-06	0.000558	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—UMPS—stomach cancer	8.43e-06	0.000555	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	8.31e-06	0.000547	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—UMPS—stomach cancer	8.23e-06	0.000541	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ALB—stomach cancer	8.09e-06	0.000532	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALDH7A1—stomach cancer	8.09e-06	0.000532	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PLCE1—stomach cancer	8.09e-06	0.000532	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	8.02e-06	0.000527	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	8.02e-06	0.000527	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—BMP2—stomach cancer	7.93e-06	0.000522	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—F2R—stomach cancer	7.93e-06	0.000522	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	7.84e-06	0.000516	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	7.84e-06	0.000516	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ECHS1—stomach cancer	7.84e-06	0.000516	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PDHA1—stomach cancer	7.84e-06	0.000516	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	7.8e-06	0.000513	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—BMP2—stomach cancer	7.76e-06	0.00051	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—F2R—stomach cancer	7.76e-06	0.00051	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—UMPS—stomach cancer	7.75e-06	0.00051	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	7.72e-06	0.000508	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CD44—stomach cancer	7.67e-06	0.000505	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	7.67e-06	0.000505	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PDHA1—stomach cancer	7.65e-06	0.000503	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ECHS1—stomach cancer	7.65e-06	0.000503	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	7.63e-06	0.000502	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	7.55e-06	0.000497	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—HRAS—stomach cancer	7.49e-06	0.000493	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	7.47e-06	0.000492	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	7.46e-06	0.00049	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TYMP—stomach cancer	7.37e-06	0.000485	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—FADS1—stomach cancer	7.37e-06	0.000485	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	7.36e-06	0.000484	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	7.31e-06	0.000481	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	7.29e-06	0.00048	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	7.26e-06	0.000477	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PDHA1—stomach cancer	7.21e-06	0.000474	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ECHS1—stomach cancer	7.21e-06	0.000474	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TYMP—stomach cancer	7.19e-06	0.000473	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—FADS1—stomach cancer	7.19e-06	0.000473	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	7.06e-06	0.000465	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	7.06e-06	0.000464	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	6.91e-06	0.000454	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	6.9e-06	0.000454	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SREBF2—stomach cancer	6.9e-06	0.000454	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RPS6—stomach cancer	6.9e-06	0.000454	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—RORA—stomach cancer	6.82e-06	0.000449	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	6.79e-06	0.000446	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TYMP—stomach cancer	6.78e-06	0.000446	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—FADS1—stomach cancer	6.78e-06	0.000446	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	6.76e-06	0.000445	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	6.75e-06	0.000444	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SREBF2—stomach cancer	6.74e-06	0.000443	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—RORA—stomach cancer	6.66e-06	0.000438	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	6.64e-06	0.000437	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	6.61e-06	0.000435	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	6.58e-06	0.000432	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPP2R1A—stomach cancer	6.52e-06	0.000429	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	6.52e-06	0.000429	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTP1—stomach cancer	6.4e-06	0.000421	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALDOB—stomach cancer	6.39e-06	0.00042	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SREBF2—stomach cancer	6.35e-06	0.000417	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	6.34e-06	0.000417	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—HMOX1—stomach cancer	6.31e-06	0.000415	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—RORA—stomach cancer	6.27e-06	0.000413	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALDOB—stomach cancer	6.24e-06	0.00041	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	6.2e-06	0.000408	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	6.03e-06	0.000397	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.03e-06	0.000396	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.01e-06	0.000395	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	6e-06	0.000395	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	5.99e-06	0.000394	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—TYMS—stomach cancer	5.95e-06	0.000391	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALOX5—stomach cancer	5.94e-06	0.000391	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	5.9e-06	0.000388	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTM1—stomach cancer	5.88e-06	0.000387	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALDOB—stomach cancer	5.88e-06	0.000387	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	5.87e-06	0.000386	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	5.85e-06	0.000385	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—DPYD—stomach cancer	5.84e-06	0.000384	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALOX5—stomach cancer	5.8e-06	0.000381	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	5.8e-06	0.000381	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	5.73e-06	0.000377	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—DPYD—stomach cancer	5.7e-06	0.000375	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	5.61e-06	0.000369	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	5.58e-06	0.000367	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ERCC2—stomach cancer	5.53e-06	0.000364	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALOX5—stomach cancer	5.46e-06	0.000359	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	5.45e-06	0.000358	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—DPYD—stomach cancer	5.38e-06	0.000354	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	5.33e-06	0.000351	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	5.32e-06	0.00035	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.3e-06	0.000348	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	5.27e-06	0.000346	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	5.21e-06	0.000343	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MTHFR—stomach cancer	5.2e-06	0.000342	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTT1—stomach cancer	5.17e-06	0.00034	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	5.15e-06	0.000339	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP2A6—stomach cancer	5.11e-06	0.000336	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FYN—stomach cancer	5.05e-06	0.000332	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTT1—stomach cancer	5.04e-06	0.000332	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2A6—stomach cancer	4.99e-06	0.000328	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKR1C3—stomach cancer	4.97e-06	0.000327	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FYN—stomach cancer	4.94e-06	0.000325	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKR1C3—stomach cancer	4.85e-06	0.000319	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ENO1—stomach cancer	4.84e-06	0.000319	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CAV1—stomach cancer	4.79e-06	0.000315	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOA1—stomach cancer	4.78e-06	0.000315	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	4.78e-06	0.000315	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.76e-06	0.000313	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTT1—stomach cancer	4.75e-06	0.000313	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	4.74e-06	0.000312	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ENO1—stomach cancer	4.73e-06	0.000311	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP2A6—stomach cancer	4.7e-06	0.000309	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	4.68e-06	0.000308	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	4.64e-06	0.000305	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKR1C3—stomach cancer	4.57e-06	0.000301	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ENO1—stomach cancer	4.45e-06	0.000293	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	4.42e-06	0.000291	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	4.34e-06	0.000286	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CD44—stomach cancer	4.29e-06	0.000282	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	4.25e-06	0.00028	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARG—stomach cancer	4.21e-06	0.000277	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	4.21e-06	0.000277	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	4.2e-06	0.000276	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CD44—stomach cancer	4.19e-06	0.000276	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.17e-06	0.000274	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	4.12e-06	0.000271	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	4.11e-06	0.00027	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	4.01e-06	0.000264	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	3.99e-06	0.000263	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CD44—stomach cancer	3.95e-06	0.00026	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	3.92e-06	0.000258	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	3.91e-06	0.000257	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APC—stomach cancer	3.84e-06	0.000252	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALB—stomach cancer	3.79e-06	0.000249	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APC—stomach cancer	3.75e-06	0.000247	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	3.67e-06	0.000242	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPP2R1A—stomach cancer	3.65e-06	0.00024	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NOS3—stomach cancer	3.63e-06	0.000238	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	3.59e-06	0.000236	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTP1—stomach cancer	3.58e-06	0.000236	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPP2R1A—stomach cancer	3.56e-06	0.000234	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	3.56e-06	0.000234	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMOX1—stomach cancer	3.53e-06	0.000232	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	3.5e-06	0.00023	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTP1—stomach cancer	3.5e-06	0.00023	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	3.5e-06	0.00023	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	3.49e-06	0.000229	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMOX1—stomach cancer	3.45e-06	0.000227	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	3.42e-06	0.000225	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	3.42e-06	0.000225	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPP2R1A—stomach cancer	3.36e-06	0.000221	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	3.34e-06	0.00022	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	3.34e-06	0.000219	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TYMS—stomach cancer	3.33e-06	0.000219	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—stomach cancer	3.32e-06	0.000218	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	3.3e-06	0.000217	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTP1—stomach cancer	3.29e-06	0.000217	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTM1—stomach cancer	3.29e-06	0.000217	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	3.27e-06	0.000215	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	3.26e-06	0.000215	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TYMS—stomach cancer	3.25e-06	0.000214	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMOX1—stomach cancer	3.25e-06	0.000214	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	3.23e-06	0.000213	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	3.22e-06	0.000212	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTM1—stomach cancer	3.21e-06	0.000211	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	3.19e-06	0.00021	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	3.15e-06	0.000207	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	3.12e-06	0.000205	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ERCC2—stomach cancer	3.09e-06	0.000204	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TYMS—stomach cancer	3.06e-06	0.000201	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	3.03e-06	0.0002	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTM1—stomach cancer	3.03e-06	0.000199	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ERCC2—stomach cancer	3.02e-06	0.000199	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	2.98e-06	0.000196	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	2.97e-06	0.000195	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	2.91e-06	0.000192	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTHFR—stomach cancer	2.91e-06	0.000191	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ERCC2—stomach cancer	2.85e-06	0.000187	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTHFR—stomach cancer	2.84e-06	0.000187	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	2.83e-06	0.000186	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	2.81e-06	0.000185	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	2.76e-06	0.000182	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	2.76e-06	0.000181	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	2.75e-06	0.000181	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	2.7e-06	0.000178	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	2.69e-06	0.000177	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAV1—stomach cancer	2.68e-06	0.000177	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOA1—stomach cancer	2.68e-06	0.000176	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTHFR—stomach cancer	2.68e-06	0.000176	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	2.63e-06	0.000173	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	2.63e-06	0.000173	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—JUN—stomach cancer	2.63e-06	0.000173	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAV1—stomach cancer	2.62e-06	0.000172	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOA1—stomach cancer	2.61e-06	0.000172	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	2.57e-06	0.000169	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—JUN—stomach cancer	2.57e-06	0.000169	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.56e-06	0.000169	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	2.56e-06	0.000168	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	2.55e-06	0.000168	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	2.5e-06	0.000164	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	2.49e-06	0.000164	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	2.49e-06	0.000163	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAV1—stomach cancer	2.47e-06	0.000162	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOA1—stomach cancer	2.46e-06	0.000162	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	2.43e-06	0.00016	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARG—stomach cancer	2.36e-06	0.000155	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARG—stomach cancer	2.3e-06	0.000151	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	2.29e-06	0.000151	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	2.27e-06	0.000149	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	2.24e-06	0.000148	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	2.22e-06	0.000146	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	2.17e-06	0.000143	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARG—stomach cancer	2.17e-06	0.000143	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	2.12e-06	0.00014	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALB—stomach cancer	2.12e-06	0.00014	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MYC—stomach cancer	2.11e-06	0.000139	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALB—stomach cancer	2.07e-06	0.000136	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	2.07e-06	0.000136	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MYC—stomach cancer	2.07e-06	0.000136	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	2.07e-06	0.000136	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CA—stomach cancer	2.04e-06	0.000134	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NOS3—stomach cancer	2.03e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	2.02e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	2.02e-06	0.000133	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NOS3—stomach cancer	1.98e-06	0.00013	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	1.95e-06	0.000128	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALB—stomach cancer	1.95e-06	0.000128	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	1.91e-06	0.000126	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NOS3—stomach cancer	1.87e-06	0.000123	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—stomach cancer	1.86e-06	0.000122	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—stomach cancer	1.81e-06	0.000119	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	1.79e-06	0.000118	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	1.75e-06	0.000115	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TP53—stomach cancer	1.73e-06	0.000114	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—stomach cancer	1.71e-06	0.000112	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TP53—stomach cancer	1.7e-06	0.000112	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	1.66e-06	0.000109	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	1.62e-06	0.000107	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—stomach cancer	1.59e-06	0.000104	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—stomach cancer	1.55e-06	0.000102	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.14e-06	7.51e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CA—stomach cancer	1.11e-06	7.33e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.05e-06	6.91e-05	CbGpPWpGaD
